The first three quarters of drug sales 590 billion average profit margin 2.1%

On November 5th, the 6th China Growth Pharmaceutical Enterprise Development Forum was held in Jinan. According to the operation of the pharmaceutical circulation market released by Inspector Wen Jiexing of the Department of Marketing of the Ministry of Commerce in the first three quarters of the year, the total sales volume of the seven categories of pharmaceutical products was 590 billion yuan, and the profit was 9.05 billion yuan, with an average profit margin of 2.1%.

According to the statistics of the Ministry of Commerce, in 2010, the total sales volume of the pharmaceutical distribution industry in China reached 708.4 billion yuan, a year-on-year increase of 24.6%, of which pharmaceutical sales reached 127.5 billion yuan, an increase of nearly 20%. In the first to third quarter of this year, the total volume of seven categories of pharmaceutical products was 590 billion yuan, a year-on-year increase of 17%, a profit of 9.05 billion yuan, an average profit margin of 2.1%, and a gross profit margin of 8.5%. The profitability of key enterprises continued to increase.

"In May this year, the Ministry of Commerce issued the outline of the development plan for the "12th Five-Year" drug distribution industry, which has played a certain role in promoting the development of drug circulation reform; mergers and acquisitions and restructuring of enterprises have also promoted the adjustment of pharmaceutical circulation structure." Wen Zaixing said .

At present, the number of people participating in basic medical insurance for urban and rural residents in China exceeds 1.26 billion. The expansion of medical insurance coverage has boosted the rapid growth of grass-roots drug use. In the first three quarters, sales reached 42.55 billion yuan, of which 6.08 billion yuan were for sales at or below the county level. The medical unit’s sales amounted to 4.26 billion yuan. (Chen Hao)